DalsnaFinance › IPOs › Veradermics › IPO
VeraDermics, Inc completed its initial public offering on NYSE on February 4, 2026, pricing at $17.00 a share.
| Ticker | MANE |
|---|---|
| Exchange | NYSE |
| Status | Completed |
| Listing date | February 4, 2026 |
| Offering price | $17.00 |
| Shares offered | 15,077,647 |
| Total raised | $256M |
VeraDermics, Inc sold 15,077,647 shares at $17.00 each on NYSE. Multiplied out, that is $256.3 million in gross proceeds, the figure before underwriting discounts and offering expenses, and it agrees with the $256 million total recorded for the deal.
Measured by money raised, VeraDermics, Inc was the 117th largest of 473 completed IPOs with a recorded deal size that this site tracks since October 5, 2024. The median deal in the same window raised $200 million.
Among the 126 listings on NYSE alone, it is the 45th largest.
February 2026 saw 41 completed IPOs in the site's data; by amount raised, VeraDermics, Inc was the 9th largest of the 41 deals with a recorded size.
Its $17.00 offer price was tied for the 96th highest (level with 12 other listings) of the 479 listings in the window with a recorded price. A share price on its own says nothing about a company's value; it depends on how many shares exist.
VeraDermics, Inc — quote, profile and latest news →
Source: SEC EDGAR filings for VeraDermics, Inc. This page is general information, not investment advice.